- Home
- S vs TERN Comparison
S vs TERN Comparison
Compare S & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | S | TERN |
|---|---|---|
| Founded | 2013 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 4.8B |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | S | TERN |
|---|---|---|
| Price | $13.30 | $52.75 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 32 | 11 |
| Target Price | $19.50 | ★ $46.72 |
| AVG Volume (30 Days) | ★ 7.8M | 6.4M |
| Earning Date | 03-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 8.04 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,001,278,000.00 | N/A |
| Revenue This Year | $22.84 | N/A |
| Revenue Next Year | $17.32 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 21.89 | N/A |
| 52 Week Low | $12.15 | $1.87 |
| 52 Week High | $21.40 | $53.19 |
Technical Indicators
Market Signals| Indicator | S | TERN |
|---|---|---|
| Relative Strength Index (RSI) | 46.55 | 75.33 |
| Support Level | $12.33 | $38.99 |
| Resistance Level | $15.28 | N/A |
| Average True Range (ATR) | 0.65 | 1.54 |
| MACD | -0.13 | 0.24 |
| Stochastic Oscillator | 42.25 | 94.85 |
Price Performance
Historical ComparisonAbout S SentinelOne Inc.
SentinelOne is a cloud-based cybersecurity company specializing in endpoint protection. SentinelOne's primary offering is its Singularity platform that offers a single pane of glass for an enterprise to detect and respond to security threats attacking its IT infrastructure. The California-based firm was founded in 2013 and went public in 2021.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.